Home/Filings/4/0001209191-23-004219
4//SEC Filing

Harford Simon N.R. 4

Accession 0001209191-23-004219

CIK 0001322505other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 4:05 PM ET

Size

5.2 KB

Accession

0001209191-23-004219

Insider Transaction Report

Form 4
Period: 2023-01-19
Harford Simon N.R.
CFO and Treasurer
Transactions
  • Sale

    Common Stock

    2023-01-19$43.80/sh1,776$77,78932,791 total
Footnotes (2)
  • [F1]Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  • [F2]Represents 13,497 shares of common stock and 19,294 restricted stock units. Includes 1,272 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the "ESPP") on November 30, 2022.

Issuer

ALBIREO PHARMA, INC.

CIK 0001322505

Entity typeother

Related Parties

1
  • filerCIK 0001443705

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:05 PM ET
Size
5.2 KB